- Prolia: Uses, Dosage, Side Effects, Warnings - Drugs. com
Prolia (denosumab) and Reclast (zoledronic acid) are injections that can be used to treat or prevent osteoporosis
- Denosumab - Wikipedia
Denosumab, sold under the brand name Prolia among others, is a human monoclonal antibody used for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone
- Denosumab (subcutaneous route) - Mayo Clinic
Denosumab injection is used to treat osteoporosis (thinning of the bones) in women who have an increased risk for fractures after menopause, and osteoporosis in men It is given when other medicines cannot be used or after other medicines did not work well
- Denosumab - StatPearls - NCBI Bookshelf
Denosumab, a bone anti-resorptive medication, treats osteoporosis and various bone-related disorders
- Prolia Injection (Denosumab): Uses Side Effects - Cleveland Clinic
DENOSUMAB (den oh sue mab) slows bone breakdown Prolia is used to treat osteoporosis in women after menopause and in men, and in people who are taking corticosteroids for 6 months or more
- Denosumab Injection: MedlinePlus Drug Information
Denosumab injection products come as a solution (liquid) to be injected subcutaneously (under the skin) in your upper arm, upper thigh, or stomach area It is usually injected by a doctor or nurse in a medical office or clinic
- Prolia (Prolia, Jubbonti, Wyost) - Uses, Side Effects, and More
What is denosumab used for? Denosumab (Prolia, Jubbonti, Wyost) is commonly used to treat osteoporosis, a condition in which the bones are thinner, weaker, and more prone to breakage
- Denosumab: Bone Loss Uses, Side Effects, Warnings, Dosage - MedicineNet
Denosumab is a lab-made human monoclonal immunoglobulin G2 (IgG2) antibody medication used to reduce bone loss in patients at high risk for bone fractures due to postmenopausal osteoporosis, cancers or other conditions
|